
At RAD 2025, Eli Lilly revealed promising results for lebrikizumab in treating atopic dermatitis in patients with skin of color.

At RAD 2025, Eli Lilly revealed promising results for lebrikizumab in treating atopic dermatitis in patients with skin of color.

At RAD 2025, pediatric dermatologist Lisa Swanson, MD, and allergist Anne Marie Singh, MD, led a dual session aimed at demystifying the connection between food allergy and atopic dermatitis.

At the 2025 Revolutionizing Atopic Dermatitis Conference, Leon Kircik, MD, highlighted the safety of JAK inhibitors, clarified misconceptions around boxed warnings, and discussed the clinical relevance of recent label updates for abrocitinib.

At RAD 2025, Tiffany Mayo, MD, emphasized the need for clinicians to recognize shared inflammatory mechanisms between AD and AA.

Data presented at the 2025 RAD Conference shows dupilumab improves daily functioning, mental health, and social aspects in patients with atopic dermatitis.

Catch up on coverage from the first day of the 2025 Revolutionizing Atopic Dermatitis Conference held in Nashville, Tennessee.

At RAD 2025, Mona Shahriari, MD, emphasized the cumulative life course impairment of AD in pediatric and adult patients, highlighting its impact on sleep, mental health, family well-being, and quality of life.

Discover groundbreaking insights from the RAD 2025 conference on roflumilast's potential to transform treatment for infant atopic dermatitis.

At RAD 2025, Jonathan Silverberg, MD, PhD, MPH, provided an in-depth look at the clinical integration of newly approved biologics nemolizumab and lebrikizumab in AD.

A poster at RAD 2025 detailed the patient-reported outcomes across skin types and racial groups.

Co-chairs Jonathan Silverberg, MD, PhD, MPH, and Raj Chovatiya, MD, PhD, MSCI, gave insight into what attendees can look forward to at this year's meeting.

Arcutis Biotherapeutics showcases promising long-term results of Zoryve for atopic dermatitis in young children at RAD 2025, emphasizing safety and efficacy.

Discover the latest breakthroughs in atopic dermatitis treatment and expert insights from the RAD dermatology conference in Nashville.

Catch up on what to expect at this year's RAD conference in Nashville, Tennessee.

Tristan Hasbargen, PA-C, led a hands-on suturing workshop at the Fall Clinical NP/PA Conference, enhancing skills in surgical dermatology.

Jonathan Silverberg, MD, PhD, MPH, walks through what to look out for in AD management.

Jonathan Silverberg, MD, PhD, MPH, shares his insights on treating and managing CHE.

Explore cutting-edge insights and networking opportunities at this year's Fall Clinical Dermatology Conference for PAs and NPs, focusing on dermatology education and innovative treatments.

Catch up on coverage from the last day of the 2025 Fall Clinical Dermatology Conference for PAs and NPs held in Orlando, Florida.

Clinicians learn to navigate salary negotiations and contracts effectively, focusing on value and strategic insights for career empowerment.

Heather Gates, PA-C, shares insights on the importance of continuous learning, mentorship, and legislative reform for PAs and NPs in dermatology.

Evan Rieder, MD, shares effective strategies to enhance dermatology practice efficiency by addressing psychological aspects of patient care and setting professional boundaries.

Discover essential business metrics for PAs in dermatology, empowering practice ownership and driving sustainable growth through data-driven strategies.

Dermatology Times has compiled a list of dermatological meetings taking place during the month of June.

Catch up on coverage from the third day of the 2025 Fall Clinical Dermatology Conference for PAs and NPs held in Orlando, Florida.

Discover innovative strategies for AK treatment from Darrell Rigel, MD, MS, at the latest Fall Clinical PA/NP conference.

Discover the latest advancements in aesthetics as Heather Gates, PA-C, shares innovative techniques and emerging technologies from this groundbreaking workshop.

Ben Lockshin, MD, FAAD, covered ways in which GLP-1 RAs can be utilized when treating psoriatic disease.

Chronic hand eczema poses diagnostic challenges and impacts quality of life, but emerging JAK inhibitors offer promising new treatment options.

Catch up on coverage from the second day of the 2025 Fall Clinical Dermatology Conference for PAs and NPs held in Orlando, Florida.